Provenienza dei contatti di primo grado di Michelle Kim-Danely
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Autobahn Labs, Inc.
 Autobahn Labs, Inc. Medical/Nursing ServicesHealth Services Autobahn Labs, Inc. is a virtual incubator that partners with research institutions to accelerate the advancement of early-stage drug discovery and development. The company is based in Palo Alto, CA. The organization invests intellectual, financial, and physical capital to efficiently move projects from feasibility to novel drug candidates. Autobahn Labs was created by Samsara Biocapital, Evotec, and KCK Ltd.
7
| Holding Company | Medical/Nursing Services | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Michelle Kim-Danely tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| APPLIED MATERIALS, INC. | Industrial Machinery | Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | President | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| GERON CORPORATION | Biotechnology | Director/Board Member | |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Pharmaceuticals: Major | Director/Board Member | |
| AGENUS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| KINEMED INC | Miscellaneous Commercial Services | Chief Executive Officer | |
Piramed Ltd.
 Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
| NURIX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Doctorate Degree | |
Redpoint Ventures
 Redpoint Ventures Investment ManagersFinance Redpoint Ventures (Redpoint Ventures) is an independent venture capital firm founded in 1999 by Jeffrey Brody, Tom Dyal, Tim Haley, Brad Jones, John Walecka and Geoff Yang. The firm is headquartered in Woodside, California. | Investment Managers | Chief Tech/Sci/R&D Officer | |
Celltech Chiroscience Plc
 Celltech Chiroscience Plc Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Celltech Chiroscience Plc is a research-based pharmaceutical group. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The University of Manchester | College/University | Corporate Officer/Principal | |
| Rice University | College/University | Undergraduate Degree Doctorate Degree | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | President | |
FirstMark Capital LLC
 FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
| Indiana University | College/University | Undergraduate Degree | |
| Indian Institute of Technology Kanpur | College/University | Graduate Degree | |
Cancer Research UK
 Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
New York Academy of Sciences
 New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| POLYPID LTD. | Pharmaceuticals: Major | Director/Board Member | |
Bright Capital LLC
 Bright Capital LLC Investment ManagersFinance Bright Capital LLC (Bright Capital) is a venture capital subsidiary of Ru-Com LLC founded in 2010 by Mikhail Anatolevich Abyzov, Boris Aleksandrovich Ryabov and Mikhail Chuchkevich. The firm is headquartered in Moscow, Russia. | Investment Managers | Private Equity Investor | |
FloDesign Sonics, Inc.
 FloDesign Sonics, Inc. Miscellaneous Commercial ServicesCommercial Services FloDesign Sonics, Inc. provides acoustic technology for separations and filtrations. It develops technology that sound vibrations to filter fluids including blood. The firm also develops filter-less acoustophoretic separation technology, and separate multiple types of particles of varying sizes including water and oil, blood cells, CHO cells, emulsified oils, algae, metals, and bacteria. The company was founded by Bart Lipkens, Stanley Kowalski III, Walter Presz and Louis Masi in 2009 and is headquartered in Wilbraham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Chairman | |
| PROTAGENIC THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Founder Consultant / Advisor Private Equity Investor Director of Finance/CFO Private Equity Investor | |
| University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree | |
Nitrase Therapeutics, Inc.
 Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Miscellaneous Commercial Services | Chairman | |
Hox Therapeutics Ltd.
 Hox Therapeutics Ltd. BiotechnologyHealth Technology Hox Therapeutics Ltd. develops therapeutics for cancer diseases based on the role of HOX genes. The private company is based in Guildford, UK. | Biotechnology | Director/Board Member | |
| MINK THERAPEUTICS, INC. | Biotechnology | Founder | |
MiroBio Ltd.
 MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Merck, Sharpe & Dohme | Director/Board Member | ||
| JIYA ACQUISITION CORP. | Financial Conglomerates | Chairman Director/Board Member Director of Finance/CFO | |
| Theia Therapeutics, Inc. | Director/Board Member Director of Finance/CFO | ||
Nalo Therapeutics, Inc.
 Nalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nalo Therapeutics, Inc. is a company that focuses on developing therapeutics to address unmet needs in cancer. Nalo Therapeutics is based in Belmont, CA and the CEO of the company is Keith Wilson. The company targets oncogenic driver mutations and/or proteins that are often difficult to drug. The company was founded in 2017 and collaborates with UCSF scientific cofounders. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| MIMEDX GROUP, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor |
Statistiche
Distribuzione geografica
| Stati Uniti | 38 |
| Regno Unito | 7 |
| Israele | 3 |
| India | 3 |
| Svizzera | 2 |
Settori
| Health Technology | 25 |
| Commercial Services | 10 |
| Finance | 9 |
| Consumer Services | 7 |
| Producer Manufacturing | 2 |
Posizioni
| Director/Board Member | 78 |
| Corporate Officer/Principal | 36 |
| Independent Dir/Board Member | 25 |
| Chief Tech/Sci/R&D Officer | 13 |
| Chairman | 11 |
Contatti più connessi
| Insiders | |
|---|---|
| Srini Akkaraju Akkaraju | 55 |
| Perry Karsen | 38 |
| Robert Stein | 34 |
| Richard D. van Doren | 14 |
| Stephen Shuttleworth | 13 |
| Nety Krishna | 7 |
| Thomas Hanke | 4 |
- Borsa valori
- Insiders
- Michelle Kim-Danely
- Connessioni Società
